KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Recursion Pharmaceuticals (RXRX) over the last 6 years, with Q3 2025 value amounting to 0.01.

  • Recursion Pharmaceuticals' Debt Ratio fell 6237.86% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 6237.86%. This contributed to the annual value of 0.02 for FY2024, which is 98457.28% up from last year.
  • Per Recursion Pharmaceuticals' latest filing, its Debt Ratio stood at 0.01 for Q3 2025, which was down 6237.86% from 0.02 recorded in Q2 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Debt Ratio peaked at 0.04 during Q2 2024, and registered a low of 0.0 during Q4 2022.
  • Its 5-year average for Debt Ratio is 0.01, with a median of 0.0 in 2023.
  • In the last 5 years, Recursion Pharmaceuticals' Debt Ratio crashed by 9781.5% in 2022 and then soared by 220858.4% in 2024.
  • Recursion Pharmaceuticals' Debt Ratio (Quarter) stood at 0.0 in 2021, then decreased by 26.3% to 0.0 in 2022, then soared by 128.57% to 0.0 in 2023, then soared by 984.57% to 0.02 in 2024, then dropped by 21.48% to 0.01 in 2025.
  • Its Debt Ratio stands at 0.01 for Q3 2025, versus 0.02 for Q2 2025 and 0.02 for Q1 2025.